The number of hospital discharges for hyperplasia of the prostate in Spain is projected to show a consistent upward trend from 2024 to 2028, starting at 30.3 thousand in 2024 and reaching 32.79 thousand by 2028. Comparing the year-on-year variation, the increment ranges from 2.07% to 2.69% annually. The Compound Annual Growth Rate (CAGR) over this forecasted period is approximately 2.03%, indicating a steady rise in hospital discharges.
For future trends, several factors should be monitored, including advancements in medical treatments, early diagnosis programs, and the impact of aging populations. Close attention to healthcare policy changes and technological innovations that may reduce hospitalization could significantly alter these projections.
